Early Intervention in Bipolar Disorder

Name: Early Intervention in Bipolar Disorder
Start: 2022-11-02T12:00:00-04:00
End: 2022-11-02T13:00:00-04:00

Webinar November 2 12:00 pm to 1:00 pm EDT

Home
Events
Early Intervention in Bipolar Disorder

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Early Intervention in Bipolar Disorder

During this webinar, Dr. Goldberg and Dr. Tohen will discuss the importance of early intervention in patients diagnosed with bipolar disorder. Together they will share their clinical experience and discuss the implications of early versus delayed intervention and identify and explore potential treatment options in bipolar disorder.

Objectives:

Describe the implications of early versus later intervention in bipolar disorder
Explore suitable treatment options in bipolar disorder

Featuring

Joseph Goldberg, MD

Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai

Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”

Mauricio Tohen, MD, DrPH, MBA

Chairman, Department of Psychiatry and Behavioral Sciences, Distinguished University Professor, University of New Mexico

Mauricio Tohen, MD, DrPH, MBA, is a University Distinguished Professor and Chairman of the Department of Psychiatry at the University of New Mexico Health Science Center, Albuquerque NM. From 2009 to 2013 he was a Professor of Psychiatry and The Krus Endowed Chair in Psychiatry at the University of Texas Health Science Center at San Antonio. Dr. Tohen received his medical degree from the National University of Mexico and his Doctor of Public Health degree in Epidemiology from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto, a clinical fellowship at McLean Hospital and Harvard Medical School, and a teaching fellowship in Epidemiology at the Harvard School of Public Health. From 1988 to 1997, Dr. Tohen was the Clinical Director of the Bipolar and Psychotic Disorders Program at McLean Hospital. From 1997 to 2008 he was a member of Lilly Research Laboratories reaching the senior-most scientific level of Distinguished Lilly Scholar. In 2009 he joined the University of Texas Health Science Center at San Antonio as the Head of the Division of Mood and Anxiety Disorders. Dr. Tohen received a National Service Award in Psychiatric Epidemiology from the National Institute of Mental Health (NIMH) and Harvard University. He also received a FIRST award from the NIMH, the Pope Award from McLean Hospital, and a NARSAD Young Investigator Award and the Simon Bolivar Award from the American Psychiatric Association. In 2014 he was named by Thomson Reuter’s “The World’s Most Influential Scientific Minds, 2014”. Honorees were the scientists who ranked in the Top 1 percent by citations of their published work in 21 broad fields between 2002 and 2012.

Jason Carter, PharmD

Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Speakers Dr. Joseph Goldberg and Dr. Mauricio Tohen are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Jason Carter, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Related Events

Meet the New PsychU PTSD Section Advisor: Dr. James Murrough
April 23 12:00 pm to 1:00 pm
Using a Narrative Approach Therapy in Addressing PTSD Self-Stigma
June 4 12:00 pm to 1:00 pm

Registration

Related Resources

Digital Dialogue Series Part 4

Interview April 2, 2025

Digital Therapeutics are health software that treat or alleviate a condition by generating and delivering an intervention. This mini series aims to deepen our understanding of this innovation.
World Bipolar Day – Bipolar Together

Video March 28, 2025

Join us as both providers and patients share their thoughts and perspectives of on the significance of World Bipolar Day and the impact of living with bipolar disorder.
Understanding Caregivers’ Perspectives: Agitation in Alzheimer’s Dementia

On-Demand Webinar March 27, 2025

Join us as we explore the caregivers’ insights on the “most bothersome” symptoms and what they view as meaningful improvements or worsening in agitation.

Event Navigation

« Pathophysiology Of Agitation Associated With Alzheimer’s Dementia: The Potential Role Of The Norepinephrine, Serotonin, & Dopamine (NSD) Neurotransmitter Systems
Schizophrenia Treatment Goals & Shared Decision Making: A Practice-Based Learning Webinar »

Join today for instant access to all PsychU content, events, and more!

Membership is free!

"*" indicates required fields

Name*

First Last

Occupational Category*

Specialty*

Adult

Family Medicine

Geriatric

Internal Medicine

Long Term Care

Pediatric

Psychiatry

How did you hear about PsychU?*

Street Address*

Country*

Zip / Postal Code*

City*

State / Province / Region*

Phone Number*

State License Number

NPI Number

State License Number*

NPI Number*

NPI Exception

I certify that I am a Health Care Provider, but I do not have a NPI Number.

Choose Your Unique Login

User Name*

Your username can only contain lowercase letters (a-z) and numbers. Username cannot be the same as email address.

Email*

Enter Email Confirm Email

Password*

Your password must be at least 8 characters Hint: Must use combination of lower case letters, upper case letters, numbers and special characters like !@#$.

Enter Password Confirm Password

I AGREE TO THE FOLLOWING TERMS

I agree to the following terms:*

I certify that I am a physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and/or manager of an organization and that my primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. I understand that any services and information provided on this website are supplied as a professional courtesy and I must continue to form my own conclusions and make my own decisions. I am also aware that Otsuka Pharmaceutical Development & Commercialization, Inc., Otsuka America Pharmaceutical, Inc. and their designees (“Otsuka”) intend to regularly revise this website and reserve the right to decline membership to individuals who Otsuka determines do not meet the aforementioned certification requirements.

I agree to the following terms*

By providing your name, email address, and other information, you are giving Otsuka and companies working with Otsuka permission to send you information from PsychU. Otsuka will not sell or transfer your personal information to any unaffiliated third party, without your prior written consent. Otsuka may monitor your use of the PsychU website to provide you with complimentary information about relevant educational programs based on your use the PsychU website. You agree that, should you use any material provided through PsychU you will attribute the source of that information to “PsychU sponsored by Otsuka Pharmaceutical Development & commercialization, Inc.” For additional information about how Otsuka uses your personal information, how to amend or delete your information, and how to opt out of future communications, please read Otsuka’s Privacy policy, which can be found here. By clicking “Join” and submitting your information, you agree to the terms provided above, and the terms provided in Otsuka’s Terms of Use and Privacy Policy.

Hidden

Direct Care Provider

Direct Care Provider Newsletter

False

Hidden

Clinician Newsletter

False

Hidden

Management Newsletter

False

Hidden

user_preferences_account_notifications

False

Hidden

user_preferences_webinar_emails

False

Event Registration

Submit any questions you may have regarding the topic of this Event and we will try to answer them during the live presentation:

How Did You Hear About This Event*

Date*

MM slash DD slash YYYY

Hidden

otsuka attendence page Event ID

Hidden

Event Page Registration Event ID

Meal Opt Out

Attested*

Attested

(Required)

Signature*

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS

PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.

PSYCHU MEMBERSHIP ELIGIBILITY

In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.

MEMBERSHIP & REGISTRATION

Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.

ATTENDANCE LIMITATIONS

PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.

MEAL REPORTING

The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Hidden

utm_source

Hidden

initial_source

CAPTCHA

Join PsychU Today to receive a wide array of tools and benefits

Join our multidisciplinary community that is improving mental health care… together
Quickly learn more about the topics you're interested in
Access an award-winning library of on-demand mental health resources
Gain key insights from industry expert & thought leaders

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Thank You For Attending Today’s Webinar

About This Event

Early Intervention in Bipolar Disorder

Featuring

Joseph Goldberg, MD

Mauricio Tohen, MD, DrPH, MBA

Jason Carter, PharmD

Related Events

Meet the New PsychU PTSD Section Advisor: Dr. James Murrough

Using a Narrative Approach Therapy in Addressing PTSD Self-Stigma

Registration

Related Resources

Digital Dialogue Series Part 4

World Bipolar Day – Bipolar Together

Understanding Caregivers’ Perspectives: Agitation in Alzheimer’s Dementia

Event Navigation

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Choose Your Unique Login

I AGREE TO THE FOLLOWING TERMS

Event Registration

Join PsychU Today to receive a wide array of tools and benefits

Stay Connected: